Search Results - "Richert, J. R."

Refine Results
  1. 1

    Differential diagnosis of suspected multiple sclerosis: a consensus approach by Miller, DH, Weinshenker, BG, Filippi, M, Banwell, BL, Cohen, JA, Freedman, MS, Galetta, SL, Hutchinson, M, Johnson, RT, Kappos, L, Kira, J, Lublin, FD, McFarland, HF, Montalban, X, Panitch, H, Richert, JR, Reingold, SC, Polman, CH

    Published in Multiple sclerosis (01-11-2008)
    “…Background and objectives Diagnosis of multiple sclerosis (MS) requires exclusion of diseases that could better explain the clinical and paraclinical findings…”
    Get full text
    Journal Article Conference Proceeding
  2. 2

    Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS by BUSHNELL, S. E, ZHAO, Z, STEINMAN, L, MEDORI, R, STEBBINS, C. C, CADAVID, D, BUKO, A. M, WHALLEY, E. T, DAVIS, J. A, VERSAGE, E. M, RICHERT, J. R, AXTELL, R. C

    Published in Neurology (07-08-2012)
    “…There is a significant unmet need for serum biomarkers in relapsing-remitting multiple sclerosis (RRMS) that are predictive of therapeutic response to…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Proof of concept studies for tissue-protective agents in multiple sclerosis by Mehta, LR, Schwid, SR, Arnold, DL, Cutter, GR, Aradhye, S, Balcer, LJ, Calabresi, PA, Cohen, JA, Cole, PE, Glanzman, R, Goelz, S, Inglese, M, Kapoor, R, Kappos, L, Kreitman, R, Lublin, FD, Mann, A, Marrie, RA, O'Looney, P, Polman, CH, Ravina, BM, Reingold, SC, Richert, JR, Sandrock, AW, Waubant, E

    Published in Multiple sclerosis (01-05-2009)
    “…Background There is considerable interest in tissue-protective treatments for multiple sclerosis (MS). Methods and Objectives We convened a group of MS…”
    Get full text
    Journal Article
  5. 5

    Short-Term Relapse Quantitation as a Fully Surrogate Endpoint for Long-Term Sustained Progression of Disability in RRMS Patients Treated with Natalizumab by Meyerson, L., Sandrock, A., Richert, J. R., Miao, X., Wang, Y. C.

    Published in Neurology Research International (2011)
    “…Time to sustained worsening in the expanded disability status scale as the standard for evaluating the accumulation of disability has been used as a measure of…”
    Get full text
    Journal Article
  6. 6

    Serum IL-17F does not predict poor response to IM IFN beta -1a in relapsing-remitting MS by Bushnell, SE, Zhao, Z, Stebbins, C C, Cadavid, D, Buko, A M, Whalley, E T, Davis, JA, Versage, E M, Richert, J R, Axtell, R C, Steinman, L, Medori, R

    Published in Neurology (07-08-2012)
    “…Objective: There is a significant unmet need for serum biomarkers in relapsing-remitting multiple sclerosis (RRMS) that are predictive of therapeutic response…”
    Get full text
    Journal Article
  7. 7

    Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment by Polman, C H, Reingold, S C, Barkhof, F, Calabresi, P A, Clanet, M, Cohen, J A, Cutter, G R, Freedman, M S, Kappos, L, Lublin, F D, McFarland, H F, Metz, L M, Miller, A E, Montalban, X, O'Connor, P W, Panitch, H, Richert, J R, Petkau, J, Schwid, S R, Sormani, M P, Thompson, A J, Weinshenker, B G, Wolinsky, J S

    Published in Neurology (25-03-2008)
    “…The increasing number of established effective therapies for relapsing multiple sclerosis (MS) and emerging consensus for early treatment raise practical…”
    Get full text
    Journal Article Conference Proceeding
  8. 8
  9. 9

    Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106 by Martin, R, Utz, U, Coligan, JE, Richert, JR, Flerlage, M, Robinson, E, Stone, R, Biddison, WE, McFarlin, DE, McFarland, HF

    Published in The Journal of immunology (1950) (01-03-1992)
    “…Multiple sclerosis (MS), a human demyelinating disease, is thought to be caused by an autoimmunologic process, and myelin basic protein (MBP) is considered a…”
    Get full text
    Journal Article
  10. 10

    Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens by Jacobson, S, Richert, JR, Biddison, WE, Satinsky, A, Hartzman, RJ, McFarland, HF

    Published in The Journal of immunology (1950) (01-08-1984)
    “…We have generated measles virus-specific T cell clones from a patient with multiple sclerosis who has been described previously as a strong responder to…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Antigen Presentation to HLA Class II-Restricted Measles Virus-Specific T-Cell Clones Can Occur in the Absence of the Invariant Chain by Sekaly, Rafick P., Jacobson, Steven, Richert, John R., Tonnelle, Cecile, McFarland, Henry F., Long, Eric O.

    “…A human fibroblast line expressing HLA-DR1 antigen on its surface was generated by transfection with DRα and DRβ cDNAs. Expression of the invariant chain gene…”
    Get full text
    Journal Article
  13. 13

    Diversity of T-cell receptor Vα, Vβ, and CDR3 expression by myelin basic protein-specific human T-cell clones by RICHERT, J. R, ROBINSON, E. D, CAMPHAUSEN, K, MARTIN, R, VOSKUHL, R. R, FAERBER, M. A, MCFARLAND, H. F, HURLEY, C. K

    Published in Neurology (01-10-1995)
    “…We sequenced the cDNAs of alpha and beta T-cell receptors (TCRs), including V, J, and CDR3 regions, expressed by 54 myelin basic protein (MBP)-specific T-cell…”
    Get full text
    Journal Article
  14. 14

    Open label gabapentin treatment for pain in multiple sclerosis by Houtchens, M K, Richert, J R, Sami, A, Rose, J W

    Published in Multiple sclerosis (01-08-1997)
    “…Pain is a frequent and distressing complaint in patients with multiple sclerosis (MS) and may present a difficult therapeutic problem. Conventional therapy is…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Characterization of antigen-specific T cells in multiple sclerosis twins with elevated proliferative responses to measles virus by Greenstein, JI, McFarland, HF, Richert, JR

    Published in The Journal of immunology (1950) (15-07-1986)
    “…The proliferative response to measles virus in normal individuals is low compared with the response to mumps virus. This is probably due to a low precursor…”
    Get full text
    Journal Article
  17. 17

    Polypeptide specificities of measles virus-reactive T cell lines and clones derived from a patient with multiple sclerosis by Richert, JR, Rose, JW, Reuben-Burnside, C, Kearns, MC, Jacobson, S, Mingioli, ES, Hartzman, RJ, McFarland, HF, McFarlin, DE

    Published in The Journal of immunology (1950) (01-10-1986)
    “…Eleven cloned and uncloned measles virus-specific T cell lines were generated from peripheral blood lymphocytes obtained from a patient with multiple sclerosis…”
    Get full text
    Journal Article
  18. 18

    Cytomegalovirus encephalitis associated with episodic neurologic deficits and OKT-8+ pleocytosis by RICHERT, J. R, POTOLICCHIO, S. JR, GARAGUSI, V. F, MANZ, H. J, COHAN, S. L, HARTMANN, D. P, JOHNSON, R. T

    Published in Neurology (1987)
    “…After 3 days of symptoms suggesting a viral illness, a 35-year-old man experienced three episodes of aphasia, right-sided sensory symptoms, and bifrontal…”
    Get full text
    Journal Article
  19. 19

    Measles-specific T cell clones derived from a twin with multiple sclerosis: genetic restriction studies by Richert, JR, McFarland, HF, McFarlin, DE, Johnson, AH, Woody, JN, Hartzman, RJ

    Published in The Journal of immunology (1950) (01-03-1985)
    “…The association between multiple sclerosis (MS) and HLA-DR2 suggests that the disease may be associated with an aberrant immune response, likely directed…”
    Get full text
    Journal Article
  20. 20